Institute of Social and Preventive Medicine, Medical Economics, University of Zurich, Zurich, Switzerland.
PLoS One. 2012;7(10):e45450. doi: 10.1371/journal.pone.0045450. Epub 2012 Oct 11.
Vaccination coverage rates for seasonal influenza are not meeting national and international targets. Here, we investigated whether the 2009/2010 A/H1N1 pandemic influenza affected the uptake of influenza vaccines.
METHODOLOGY/PRINCIPAL FINDINGS: In December 2009/January 2010 and April 2010, 500 randomly selected members of the general public in Germany, France, the United States, China, and Mexico were surveyed by telephone about vaccination for seasonal and A/H1N1 pandemic influenza. Also, in April 2010, 100 randomly selected general practitioners were surveyed. Adult vaccine coverage in December 2009/January 2010 for A/H1N1 pandemic and seasonal influenza were, respectively, 12% and 29% in France, 11% and 25% in Germany, 41% and 46% in the US, 13% and 30% in Mexico, and 12% and 10% in China. Adult uptake rates in April 2010 were higher in Mexico but similar or slightly lower in the other countries. Coverage rates in children were higher than in adults in the US, Mexico, and China but mostly lower in Germany and France. Germans and French viewed the threat of A/H1N1 pandemic influenza as low to moderate, whereas Mexicans, Americans, and Chinese viewed it as moderate to serious, opinions generally mirrored by general practitioners. The recommendation of a general practitioner was a common reason for receiving the pandemic vaccine, while not feeling at risk and concerns with vaccine safety and efficacy were common reasons for not being vaccinated. Inclusion of the A/H1N1 pandemic strain increased willingness to be vaccinated for seasonal influenza in the United States, Mexico, and China but not in Germany or France.
CONCLUSIONS/SIGNIFICANCE: The 2009/2010 A/H1N1 influenza pandemic increased vaccine uptake rates for seasonal influenza in Mexico but had little effect in other countries. Accurate communication of health information, especially by general practitioners, is needed to improve vaccine coverage rates.
季节性流感疫苗的接种率未达到国家和国际目标。在这里,我们调查了 2009/2010 年甲型 H1N1 流感大流行是否影响了流感疫苗的接种。
方法/主要发现:2009 年 12 月至 2010 年 1 月和 2010 年 4 月,德国、法国、美国、中国和墨西哥的 500 名随机选择的公众通过电话接受了季节性和 A/H1N1 大流行性流感疫苗接种情况调查。此外,2010 年 4 月还对 100 名随机选择的全科医生进行了调查。2009 年 12 月至 2010 年 1 月,法国成人 A/H1N1 大流行和季节性流感疫苗接种率分别为 12%和 29%,德国为 11%和 25%,美国为 41%和 46%,墨西哥为 13%和 30%,中国为 12%和 10%。2010 年 4 月,墨西哥的成人接种率较高,但其他国家的接种率相似或略低。美国、墨西哥和中国的儿童疫苗接种率高于成人,但德国和法国的儿童疫苗接种率大多低于成人。德国人和法国人认为 A/H1N1 大流行流感的威胁为低至中等,而墨西哥人、美国人和中国人则认为其威胁为中等至严重,医生的看法普遍反映了这一点。全科医生的建议是接种大流行疫苗的常见原因,而不感到有风险以及对疫苗安全性和有效性的担忧则是未接种疫苗的常见原因。在美国、墨西哥和中国,包含 A/H1N1 大流行株增加了接种季节性流感疫苗的意愿,但在德国或法国却没有。
结论/意义:2009/2010 年甲型 H1N1 流感大流行增加了墨西哥季节性流感疫苗的接种率,但对其他国家几乎没有影响。需要准确传达健康信息,特别是通过全科医生,以提高疫苗接种率。